Law360, New York (March 31, 2008, 12:00 AM ET) -- In a blow to Merck & Co. Inc. and Schering-Plough Corp., a panel of four cardiologists has reportedly recommended against using two of the companies' jointly marketed cholesterol-lowering drugs, saying the drugs may not work and should be used only as a last resort.
The doctors made the recommendation at a cardiology conference on Sunday during which researchers presented full results of the "Enhance" study, which showed that the drugs, Vytorin and Zetia, worked no better than Zocor – an older, cheaper drug – to prevent...
Doctors Slam Cholesterol Drugs Over Safety Concerns
To view the full article, take a free trial now.
